Clinical Trial Update: T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating donor-derived T lymphocytes for infections caused by adenovirus, cytomegalovirus, Epstein-Barr virus, BK virus, and Asper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Bk Virus Infection
• Cytomegalovirus Infection
• Epstein-barr Virus Infection
• Invasive Aspergillosis

Drugs mentioned

• Adoptive T-cell Therapy (virus-specific donor-derived T cells) (virus-specific donor-derived T lymphocytes)

Snippet

Sponsor: George Papanicolaou Hospital | Conditions: Opportunistic Fungal Infection, Opportunistic Viral Infection | Phase 1, Phase 2 | Status: COMPLETED